glp 1 ra ozempic How GLP-1 Prescriptions are Reshaping Food and Beverage Trends Novo Nordisk promotes new GLP-1

No evidence of cardiac, hepatic, or renal toxicity, changes in serum lipids, or clinically relevant changes in laboratory parameters, vital signs, electrocardiograms, or abnormal findings upon physical examinations have been observed

Therapeutic vaccine against DPP4 improves glucose metabolism in mice

Tirzepatide has received approval for use in patients with T2D following several phase 3 studies testing and demonstrating its marked anti-hyperglycemic efficacy and positive actions on multiple cardiovascular risk factors, associated with an excellent safety profile [2, 3]

GLP-1 community GLP-1 support group meetups & events

Drug Deliv

Health Canada Review Cites 7.1M GLP-1 Prescriptions in 2023 Health Canada's Summary Safety Review discloses 7.1 million GLP-1 receptor agonist prescriptions dispensed by Canadian retail pharmacies in 2023